Connect with us

Global Market

Global Voglibose Market Is Expected To Grow At A CAGR Of 7.2% From 2020 To 2027

Published

on

Press Release

Voglibose is often used in combination with glimepiride and metformin in the treatment of newly diagnosed type 2 diabetes patients. It is basically an alpha-glycosidase inhibitor, which delays the intestinal absorption of glucose and prevents the spike of blood glucose levels post-meal.

Postprandial hyperglycemia often associated with the increased risk of cardiovascular complications in the later life of diabetic patients. If the plasma glucose level is exceeding 140mg/dl post meal then the patient is reported to be suffering from postprandial hyperglycemia, it occurs owing to the decreased insulin sensitivity in the peripheral tissues with lower suppression of hepatic glucose post meals. Physical inactivity and exponential rise in the adoption of an unhealthy lifestyle primarily determine the clinical application of voglibose in the treatment of postprandial hyperglycemia. Type 1b glycogen storage disease is categorized as an orphan disease having a prevalence rate of 1 per 100,000 births worldwide. Voglibose has been extensively studied in the clinical trials for its therapeutic efficacy and safety for the treatment of type 1b glycogen storage disease.

Browse the full report Voglibose Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/voglibose-market

Hospital pharmacy is currently reigning the distribution channel segment for the voglibose market. The major parameter responsible for its magnificent market growth is the significant rise in public health awareness causing a large number of patients to visit hospital pharmacy with doctor’s prescription of voglibose for the treatment of postprandial hyperglycemia. Retail pharmacy is anticipated to record excellent market growth in the near future on account of the exponential growth in the generic drugs market worldwide and the capability to serve pre-diabetic patients in remote locations.

In the present scenario North America is dominating the geography segment for the voglibose market. A significant rise in the number of postprandial hyperglycemic patients and rising prevalence of obesity together determine the voglibose market growth in the region. As per the research citings provided by the Center for Disease Control and Prevention, (CDC), approximately 24.4 million U.S. citizens are suffering from type 2 diabetes. Affordable reimbursement scenario provided for the use of voglibose in the treatment of postprandial hyperglycemia further consolidates the voglibose market growth in the region. Europe is in second place on account of the rising prevalence of type 2 diabetes in the young population of the European Union. As per the latest report presented by the European Commission the type 1b glycogen storage disease occurs in 1 in 20,000 Ashkenazi Jews population residing in the Eastern European region. Asia Pacific is set to highlight faster market growth during the forecast period owing to the significant rise in obesity, sedentary lifestyle, and consumption of junk food causing diabetes and developing healthcare infrastructure.

Pharmaceutical companies actively engaged in the manufacturing of voglibose are Pfizer, Inc., Eris LifeSciences Pvt. Ltd., Macleods Pharmaceuticals Pvt., Ltd., Abbott Laboratories, Inc., Sun Pharmaceutical Industries Ltd., Cadila Healthcare, Cipla Limited, Mylan Labs Ltd., Takeda Pharmaceutical Co., Ltd, and Lupin Ltd.

Market Key Takeaways:

  • A constant rise in the number of diabetic patients diagnosed with postprandial hyperglycemia
  • Effective combination of voglibose with glimepiride and metformin used as first-line therapy for the treatment of type 2 diabetes in newly diagnosed patients
  • Affordable reimbursement scenario for the use of voglibose in the treatment of type 2 diabetes mellitus

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Microscopes Market is expected to grow at a CAGR of 7.2% from 2020 to 2027

Published

on

Press Release

Microscopes as a medical investigation device have undergone technological evolution in the last 2 centuries. Its market growth and significance have been concomitant with the technological revolution of medical science pertaining to the identification of vector-borne infections and novel drug development of its treatment. The technological advancement in the development of microscopic lenses is vital in the overall growth of the microscopic devices. The major hurdle associated with this market is the huge initial capital required for its installment and subsequent maintenance of accessories pertaining to microscopic devices.

The optical microscopes have several varieties such as phase-contrast microscopy, compound microscopy, confocal microscopy, fluorescence microscopy, etc., which altogether supports the market dominance of optical microscopes in the product segment. A significant rise in the adoption of optical microscopes among academic research institutes worldwide steers its market growth. High resolution and superior magnification and technological advancement in the optical lenses consolidate the optical microscopes market growth. Scanning probe microscopes are expected to exhibit fast market growth on account of its ability to study real-time three-dimensional objects.

Browse the full report Microscopes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/microscopes-market

Life sciences is dominating the applications segment for the microscopes market. Growing demand for the development of prophylactic treatment for pandemic diseases such as Coronavirus, Ebola, Swine Flu, and Zika virus drives the adoption of microscopes in the life sciences segment. Material science is anticipated to be the fastest-growing segment owing to the increasing research activities pertaining to nanotechnology and its useful application in day to day anthropological activities.

North America is considered as the largest market in the geography segment of microscopes market. The major features responsible for its market growth are the looming threat of antibiotics resistance to infectious diseases and huge investment in the research and development segment for the novel drug screening favors the market dominance of microscopes in the North America region. Furthermore, the domicile of major players such as Bruker Corporation, Olympus Corporation, TESCAN, Carl Zeiss Microscopy GmbH, etc. will further accentuate the microscopes market growth in the region. Europe stood in second place in the microscopes market on account of the strategic partnership between the medical device manufacturers and academic research institutes for the development of high resolution and magnification microscopy lenses. Asia Pacific is on the verge of rampant market growth in the near future owing to the growing incidence of viral infections and potential market opportunities for major players to establish subsidiaries and retail outlets.

Medical device manufacturers engaged in the manufacturing of microscopy devices are Bruker Corporation, Nikon Corporation, Olympus Corporation, Leica Microsystems, TESCAN, Carl Zeiss Microscopy GmbH, Hitachi High Technologies Corporation, JEOL Ltd. CAMECA Instruments and Thermo Fisher Scientific Corporation.

Market Key Takeaways:

  • Technological development in the microscopy devices resulting in value addition of ergonomic features such as superior lens magnification and image resolution
  • Rising prevalence of infectious diseases worldwide with a burgeoning requirement of novel drug development for its treatment
  • Huge investment by the government healthcare agencies in the healthcare segment to provide microscopic devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Left Atrial Appendage Closure Devices Market Is Expected to Grow at a CAGR of 21.6% from 2020 to 2027

Published

on

Press Release

According to the latest research citings presented by the American Heart Association (AHA), approximately 1 in 4 adults above 40 years of age have the chance of developing atrial fibrillation during their lifetime. Furthermore, men are 13% more likely to be affected by atrial fibrillation than women during their lifetime.

Endocardial left atrial appendicular devices are the largest market shareholder in the product type segment. A constant rise in the number of patients suffering from cardiac arrhythmia posing a greater risk of cardiac stroke I later part of life primarily drives its market growth. Technological advancement in the development of endocardial LAA closure devices and the capability to implant it using minimally invasive percutaneous surgical procedures has made it an effective alternative for oral anticoagulants for stroke prophylaxis in the patients suffering from non-valvular atrial fibrillation. The epicardial LAA closure devices are anticipated to register marvelous market growth during the forecast period because it cancels the need for implanting a permanent device.

Browse the full report Left Atrial Appendage Closure Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/left-atrial-appendage-closure-devices-market

Hospitals and clinics are currently leading the end-user segment for left atrial appendage closure devices market. Availability of the state of the art operation theaters and well equipped cardiac catheter laboratories determines its market growth. Ambulatory surgical centers are gaining prominence on account of its ability to provide medical assistance to patients suffering from cardiac stroke associated with atrial fibrillation residing in remote locations.

North America is presently dominating the geography segment for the left atrial appendage closure devices market. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), it is estimated that 2.7 million Americans are suffering from atrial fibrillation. Furthermore, the supportive regulatory environment provided by the FDA for the early CE certification for the left atrial appendage closure devices used for the treatment of atrial fibrillation in the U.S. further accentuates its market growth. Europe stands in the 2nd place in the regional segment for left atrial appendage closure devices market. As per the recent findings provided by the Global Burden of Disease Collaborative Network the prevalence rate of atrial fibrillation in the European region is 788 per 100,000 people. A favorable reimbursement scenario for LAA closure devices further propels the market growth in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The rising prevalence of heart stroke in the geriatric population and a significant increase in the medical tourism industry together drive the market growth in the Asia Pacific region.

Medical device manufacturers actively engaged in the production of left atrial appendage closure devices are Boston Scientific Corporation, Atricure, Inc., Abbott Laboratories, Inc., Aegis Medical Group, Biosense Webster (Johnson & Johnson), Lifetech Scientific, Lepu Medical Technology (Beijing) Co., Ltd., Occlutech International AB, Cardia, Inc., and Append Medical (MEDX Xelerator).

Market Key Takeaway:

  • Rising prevalence of atrial fibrillation worldwide
  • Technological advancement in the development of left atrial appendage closure devices making it an alternative option for oral anticoagulants
  • The supportive regulatory environment provided by the global healthcare agencies by awarding early CE certification to LAA closure devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Global Market

Global Methadone Hydrochloride Market is expected to grow at a CAGR of 2.2% from 2020 to 2027

Published

on

Press Release

Methadone hydrochloride exerts its therapeutic efficacy by working on the mu receptor present in the central nervous system, which is used in multiple formulation and concentrations of 5mg/5ml, 10mg/ml for oral administration, and 10mg/ml solution for parenteral administration. Rising prevalence of narcotic drug abuse and increasing demand for methadone hydrochloride for managing chronic pain in cancer and musculoskeletal disorders accentuates its market growth.

Opioid addiction treatment is spearheading the clinical application segment for the methadone hydrochloride market. Addiction is a psychological disorder resulting in a craving for opioid analgesics most often causing Opioid misuse means the narcotic drugs are taken without medical supervision and doctor’s prescription. As per the statistics brought forward by the World Health Organization (WHO) annually approximately 15 million worldwide are reported for opioid addiction. Oral administration of methadone hydrochloride of 5 mg or 10 mg for a few weeks is helpful is prescribed for opioid addiction treatment. Pain management therapy is significantly gaining solid grounds owing to the rising prevalence of cancer patients worldwide suffering from chronic pain. Different combinations of methadone hydrochloride and NSAIDS are used for managing chronic pain in medical conditions such as joint disorders, back pain, surgery, arthritis, etc.

Browse the full report Methadone Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/methadone-hydrochloride-market

Hospital pharmacy is holding the largest market share in the distribution channel segment for the methadone hydrochloride market. Adjustment of a precise dose of methadone hydrochloride is essential for treating opioid addiction patients which are done in the hospital pharmacy on the developed regions. Retail pharmacy is gaining tremendous traction in the developing region owing to the rising prevalence of occupational hazards causing musculoskeletal disorders, hence increases the demand for a cheap generic version of methadone hydrochloride.

North America is presently dominating the geography segment for the methadone hydrochloride market. The rising prevalence of opioid drug abuse chiefly determines its market growth. The National Institute of Health (NIH), provides vital information that annually approximately 2 million Americans are suffering from narcotic drug addiction. Affordable reimbursement scenario for the use of methadone hydrochloride as a medicinal agent in the pain management therapy further propels the market growth in the region. The market growth in Europe is primarily driven by the rising prevalence of the geriatric population suffering from chronic pain associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, joint disorders, etc. Asia Pacific is going to register steady market growth during the forecast period owing to the rising prevalence of cancer patients suffering from chronic pain and the presence of a well-established generic drug market.

Pharmaceutical companies actively engaged in providing medicines for the treatment of methadone hydrochloride are Eli Lilly & Company, Sanofi S.A., Mallinckrodt Pharmaceuticals, Siegfried AG, Roxane Laboratories, Inc., Aurolife Pharma, LLC., Elite Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Sandoz, Inc., and Rosemont Pharmaceuticals Ltd.

Market Key Takeaways:

  • Significant rise in the number of cancer patients suffering from chronic pain worldwide
  • Rising prevalence of opioid drug addiction and drug abuse among the young population throughout the globe
  • Affordable reimbursement scenario for the methadone formulations employed in pain management therapy

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Continue Reading

Trending

Copyright © 2019 Melanian News